← FDA Drug Approvals (Drugs@FDA)

ALENDRONATE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2023-05-11

Drug application

FDA Application #

ANDA214512

Application type

Abbreviated New Drug Application (Generic)

Brand name

ALENDRONATE SODIUM

Generic name

ALENDRONATE SODIUM

Active ingredients

ALENDRONATE SODIUM

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

NOVITIUM PHARMA

Manufacturer

ANI Pharmaceuticals, Inc.

First approval

2023-05-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown